The Technical Analyst
Select Language :
Jazz Pharmaceuticals PLC [JAZZ]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Jazz Pharmaceuticals PLC Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Jazz Pharmaceuticals PLC is listed at the  Exchange

-0.07% $120.42

America/New_York / 28 mar 2024 @ 16:00


Jazz Pharmaceuticals PLC: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 7 507.62 mill
EPS: 6.10
P/E: 19.74
Earnings Date: Feb 27, 2024
SharesOutstanding: 62.35 mill
Avg Daily Volume: 0.634 mill
RATING 2024-03-28
S-
Strong Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Buy
DE: Strong Buy
P/E: Strong Buy
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 19.74 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
3.36x
Company: PE 19.74 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 116.66 - 124.16

( +/- 3.12%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-06 Carr Patricia Sell 1 236 Ordinary Shares
2024-03-06 Carr Patricia Sell 700 Ordinary Shares
2024-03-07 Carr Patricia Sell 1 768 Ordinary Shares
2024-03-05 Gala Renee D Sell 3 622 Ordinary Shares
2024-03-05 Pearce Samantha Sell 2 474 Ordinary Shares
INSIDER POWER
44.31
Last 96 transactions
Buy: 362 437 | Sell: 149 101

Forecast: 16:00 - $120.39

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $120.39
Forecast 2: 16:00 - $120.39
Forecast 3: 16:00 - $120.39
SCORE
-9.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $120.42 (-0.07% )
Volume 0.378 mill
Avg. Vol. 0.634 mill
% of Avg. Vol 59.56 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Jazz Pharmaceuticals PLC

Last 12 Months

Last 12 months chart data with high, low, open and close for Jazz Pharmaceuticals PLC

RSI

Intraday RSI14 chart for Jazz Pharmaceuticals PLC

Last 10 Buy & Sell Signals For JAZZ

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35buy$122.60N/AActive
Profile picture for
            Jazz Pharmaceuticals PLC

JAZZ

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Sunosi for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease; Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia; and Zepzelca for the treatment of adult patients with metastatic small cell lung cancer. The company also offers Xywav, an oxybate product candidate, to treat EDS and cataplexy with narcolepsy and idiopathic hypersomnia; JZP-324, a low sodium oxybate formulation with the potential to provide a clinically meaningful option for narcolepsy patients; JZP385, a T-type calcium channel modulator, for the treatment of essential tremor; JZP458, a recombinant Erwinia asparaginase, for use as a component of a multi-agent chemotherapeutic regimen in the treatment of pediatric and adult patients; and JZP150 for treatment of post-traumatic stress disorder. The company has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; XL-protein GmbH; and Redx Pharma plc. Jazz Pharmaceuticals plc was incorporated in 2003 and is headquartered in Dublin, Ireland.

Last 10 Buy Signals

Date Signal @
DAOUSDMar 28 - 18:19$1.823
TONUSDMar 28 - 18:134.88
STXUSDMar 28 - 18:19$3.43
SFRXETHUSDMar 28 - 18:153 791.50
BTC.BUSDMar 28 - 18:1470 390
DPXUSDMar 28 - 18:1441.73
WEGLDUSDMar 28 - 18:1461.14
OGUSDMar 28 - 18:135.99
OETHUSDMar 28 - 18:133 547.68
JUPUSDMar 28 - 18:141.290

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.